Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy

ClinicalTrials.gov ID: NCT00974311

Public ClinicalTrials.gov record NCT00974311. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 31, 2026, 6:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Affirm: A Multinational Phase 3, Randomized, Double-blind, Placebo-controlled Efficacy And Safety Study Of Oral Mdv3100 In Patients With Progressive Castration-resistant Prostate Cancer Previously Treated With Docetaxel Based Chemotherapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a phase 3 study to compare the clinical benefit of MDV3100 versus placebo in patients with castration-resistant prostate cancer who have been previously treated with docetaxel-based chemotherapy.

Study identification

NCT ID
NCT00974311
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
1,199 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2009 (Actual)
Primary completion
Sep 15, 2011 (Actual)
Completion
Nov 2, 2017 (Actual)
Last update posted
Dec 11, 2018

2009 – 2017

United States locations

U.S. sites
98
U.S. states
26
U.S. cities
62
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35233 —
University of Alabama at Birmingham Birmingham Alabama 35294 —
Mayo Clinic Hospital Phoenix Arizona 85054 —
Premiere Oncology of Arizona Scottsdale Arizona 85258 —
Mayo Clinic Arizona Scottsdale Arizona 85259 —
Tower Cancer Research Foundation, Tower Hematology Oncology Medical Group Beverly Hills California 90211-1850 —
USC Westside Prostate Cancer Center Beverly Hills California 90211 —
City of Hope Duarte California 91010 —
Cancer Center Oncology Medical Group La Mesa California 91942 —
LAC & USC Medical Center Los Angeles California 90033 —
USC/Norris Comprehensive Cancer Center Los Angeles California 90033 —
Ronald Reagan UCLA Medical Center Los Angeles California 90095-6984 —
UCLA Los Angeles California 90095 —
c/o Prostate Oncology Specialist, Inc. Marina del Rey California 90292 —
North County Oncology Medical Clinic, Inc, Oceanside California 92056 —
Medical Oncology Associates - SD San Diego California 92123 —
Sharp Memorial Hospital Investigational Pharmacy San Diego California 92123 —
Sharp Rees-Stealy San Diego California 92123 —
UCSF Helen Diller Family Comprehensive Cancer Center San Francisco California 94115 —
City of Hope Medical Group South Pasadena California 91030 —
Stanford Hospital and Clinics Research Pharmacy Stanford California 94305 —
Stanford University Medical Center Stanford California 94305 —
Research Pharmacist Aurora Colorado 80045 —
University of Colorado Denver, Anschutz Cancer Pavilion Aurora Colorado 80045 —
C/O: Thomas Ferencz R.Ph., BCOP New Haven Connecticut 06510 —
Yale University School of Med New Haven Connecticut 06520 —
George Washington University-Medical Faculty Associates Washington D.C. District of Columbia 20037 —
Palm Beach Cancer Institute Atlantis Florida 33462 —
Palm Beach Cancer Institute Palm Beach Gardens Florida 33410 —
Palm Beach Cancer Institute Wellington Florida 33414 —
Palm Beach Cancer Institute West Palm Beach Florida 33401 —
Peachtree Hematology-Oncology Consultants, P.C. Atlanta Georgia 30318 —
University of Chicago Medical Center Chicago Illinois 60637 —
University of Chicago Chicago Illinois 60637 —
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore Maryland 21231 —
The Johns Hopkins Hospital Baltimore Maryland 21287 —
Massachusetts General Hospital (MGH) Boston Massachusetts 02114 —
Brigham & Women's Hospital (BWH) Boston Massachusetts 02115 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
Dana-Farber Cancer Institute Boston Massachusetts 02215 —
Karmanos Cancer Institute Detroit Michigan 48201 —
Weisberg Cancer Treatment Center Farmington Hills Michigan 48334 —
Mayo Clinic Rochester Minnesota 55905 —
Siteman Cancer Center City of Saint Peters Missouri 63376 —
Siteman Cancer Center-West County Creve Coeur Missouri 63141 —
Barnes-Jewish Hospital St Louis Missouri 63110-1094 —
Washington University School of Medicine St Louis Missouri 63110 —
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89128 —
Nevada Cancer Institute, an affiliate of the UC San Diego Health System Las Vegas Nevada 89135 —
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89169 —
New Mexico Oncology Hematology Consultants, Ltd. Albuquerque New Mexico 87109 —
Roswell Park Cancer Institute Buffalo New York 14263 —
Weill Cornell Medical College-New York Presbyterian Hospital New York New York 10021 —
Memorial Sloan-Kettering Cancer Center New York New York 10065 —
Weill Cornell Medical College-New York Presbyterian Hospital New York New York 10065 —
Duke University Medical Center Durham North Carolina 27710 —
Pharmaceutical Research Services Durham North Carolina 27710 —
Portland VA Medical Center Portland Oregon 97239 —
UPMC Cancer Centers McKeesport Pennsylvania 15132 —
Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104 —
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 —
University of Pittsburgh Cancer Institute Pittsburgh Pennsylvania 15232 —
UPMC Cancer Centers Pittsburgh Pennsylvania 15237 —
VA Pittsburgh Healthcare System Pittsburgh Pennsylvania 15240 —
Hollings Cancer Center Charleston South Carolina 29425 —
Medical University of South Carolina (MUSC) Charleston South Carolina 29425 —
Carolina Urologic Research Center Myrtle Beach South Carolina 29572 —
Grand Strand Urology Myrtle Beach South Carolina 29572 —
Tennessee Oncology, PLLC Chattanooga Tennessee 37404 —
Tennessee Oncology, PLLC Dickson Tennessee 37055 —
Tennessee Oncology, PLLC Franklin Tennessee 37067 —
Tennessee Oncology, PLLC Gallatin Tennessee 37066 —
Tennessee Oncology, PLLC Hermitage Tennessee 37076 —
Tennessee Oncology, PLLC Lebanon Tennessee 37087 —
Tennessee Oncology, PLLC Murfreesboro Tennessee 37129 —
Tennessee Oncology, PLLC Nashville Tennessee 37203 —
The Sarah Cannon Research Institute Nashville Tennessee 37203 —
Tennessee Oncology, PLLC Nashville Tennessee 37205 —
Tennessee Oncology, PLLC Nashville Tennessee 37207 —
Tennessee Oncology, PLLC Nashville Tennessee 37211 —
Vanderbilt University Medical Center Nashville Tennessee 37232-5536 —
Tennessee Oncology, PLLC Smyrna Tennessee 37167 —
Parkland Health and Hospital System Dallas Texas 75235 —
Texas Oncology, Sammons Cancer Center Dallas Texas 75246 —
UT Southwestern Medical Center at Dallas Dallas Texas 75390 —
Virginia Oncology Associates Chesapeake Virginia 23320 —
Virginia Oncology Associates Hampton Virginia 23666 —
Virginia Cancer Institute Mechanicsville Virginia 23116-1844 —
Virginia Cancer Institute Midlothian Virginia 23114 —
Virginia Oncology Associates Newport News Virginia 23606 —
Virginia Oncology Associates Norfolk Virginia 23502 —
Virginia Cancer Institute Richmond Virginia 23230 —
Virginia Cancer Institute Richmond Virginia 23235-4730 —
Virginia Oncology Associates Virginia Beach Virginia 23456 —
Virginia Oncology Associates Williamsburg Virginia 23188 —
Seattle Cancer Care Alliance Seattle Washington 98109 —
University of Washington Medical Center Seattle Washington 98195 —
University of Wisconsin Hospital and Clinics Madison Wisconsin 53792 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 151 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00974311, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 11, 2018 · Synced Oct 31, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00974311 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →